Viatris M&A Summary
Viatris has acquired 14 companies, including 2 in the last 5 years. A total of 4 acquisitions came from private equity firms. It has also divested 3 assets.
Viatris’ largest acquisition to date was in 2016, when it acquired Meda AB for $9.9B. It’s largest disclosed sale occurred in 2022, when it sold Viatris - Biosimilars to Biocon for $3.3B. Viatris has acquired in 5 different US states, and 7 countries. The Company’s most targeted sectors include life science (79%) and medical products (22%).
M&A Summary
-
M&A Total Activity17
- M&A Buy Activity14
- M&A Sell Activity3
- Total Sectors Invested 2
- Total Countries Invested 7
- M&A Buy/Sell Connections 15
Unlimited Searches
